Cooley Shortlisted Across Five Categories for LMG Life Sciences Americas Awards
Palo Alto – August 9, 2021 – Cooley has been shortlisted in five categories for the 2021 LMG Life Sciences Americas awards, including Corporate Firm of the Year, Licensing & Collaboration Firm of the Year, M&A Firm of the Year, Regulatory Firm to Watch and Patent Strategy Firm of the Year.
The publication also recognized six Cooley partners as finalists in their respective categories, including Div Gupta for Corporate Attorney of the Year; Kay Chandler for Licensing & Collaboration Attorney of the Year; Barbara Borden for M&A Attorney of the Year; Sanya Sukduang for General Patent Litigator of the Year – DC Metro; Mika Reiner Mayer for Patent Strategy Attorney of the Year – California; and Ivor Elrifi for Patent Strategy Attorney of the Year – New York.
LMG Life Sciences determines its award results through a rigorous research process involving in-depth firm submissions, practitioner interviews, client feedback and independent research.
Cooley’s top-tier team of life sciences and healthcare corporate, regulatory and litigation lawyers have deep US and global experience counseling on an extensive number of complex healthcare deals, regulatory issues and investigations. The firm has represented leading global life sciences companies for 40+ years and advises all players in the ecosystem, including payors, providers, companies, health IT and investors. Cooley is consistently recognized as a market leader in the field and has been the #1 firm in issuer-side life sciences IPOs since 2000.
About Cooley LLP
Clients partner with Cooley on transformative deals, complex IP and regulatory matters, and high-stakes litigation, where innovation meets the law.
Cooley has 1,300 lawyers across 17 offices in the United States, Asia and Europe.